HAEMONETICS CORP — Director's Dealing 2019

Oct 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-10-04

Reporting Person: Scanlan Jacqueline (SVP, Global Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-04	Common Stock	A	5204	—	Acquired	9899	Direct

Footnotes

F1: Represents shares earned from a performance share unit award granted to the reporting person on March 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from October 1, 2016 to September 30, 2019, as certified by the Compensation Committee of the Board of Directors on October 4, 2019.

F2: This number includes unvested restricted stock units previously reported.